Woodline Partners LP Celldex Therapeutics, Inc. Transaction History
Woodline Partners LP
- $14.3 Billion
- Q1 2025
A detailed history of Woodline Partners LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 1,188,429 shares of CLDX stock, worth $26.7 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,188,429
Previous 2,014,015
40.99%
Holding current value
$26.7 Million
Previous $50.9 Million
57.62%
% of portfolio
0.15%
Previous 0.38%
Shares
12 transactions
Others Institutions Holding CLDX
# of Institutions
189Shares Held
69.4MCall Options Held
220KPut Options Held
310K-
Wellington Management Group LLP Boston, MA8.35MShares$188 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.5MShares$146 Million9.94% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$105 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$87.6 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$84.3 Million1.45% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.05B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...